Home › Urothelial (Transitional Cell) Carcinoma › Ohio › Cleveland

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Cleveland, OH

Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #10, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Nagre-recruit

University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland
Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06262516

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

Nagre-recruitPhase 1/2

Cleveland Clinic-Taussig Cancer Center ( Site 1036), Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05562830

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2

University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Foundation, Cleveland
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Nagre-recruitPhase 1

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06966024

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Nagre-recruitPhase 3

Research Site, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07720284

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.